Vitalis Pharma is a pharmaceutical company that develops proprietary, IP-protected forms of aspirin.
Vitalis Pharma has raised $2.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.
Vitalis Pharma is headquartered in New York, United States.
Vitalis Pharma is a pharmaceutical company that develops proprietary, IP-protected forms of aspirin.
Vitalis Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vitalis Pharma — Funding & Investors." VCBacked, February 17, 2025, https://www.vcbacked.co/company/vitalis-pharma. Accessed August 7, 2026.
VCBacked. (2025). Vitalis Pharma — Funding & Investors. Retrieved August 7, 2026, from https://www.vcbacked.co/company/vitalis-pharma
{{cite web |title=Vitalis Pharma — Funding & Investors |url=https://www.vcbacked.co/company/vitalis-pharma |website=VCBacked |access-date=August 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated